Cui Wang

Dr. Cui Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2024 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
Wenchao YinWenchao Yin
Wenchao Yin
WZWencheng Zhu
Wencheng Zhu
HGHong Gao
Hong Gao
XNXiaohui Niu
Xiaohui Niu
CSChenxin Shen
Chenxin Shen
CWCui Wang
Cui Wang
Background: Gait disorder is a prominent motor symptom in Parkinson’s disease (PD), objective and quantitative assessment of gait is essential for diagnosing and treating PD, particularly in its early stage.Methods: This study utilized a non-contact gait assessment system to investigate gait characteristics between individuals with PD and healthy controls, with a focus on early-stage PD. Additionally, we trained two machine learning models to differentiate early-stage PD patients from controls and to predict MDS-UPDRS III score.Results: Early-stage PD patients demonstrated reduced stride length, decreased gait speed, slower stride and swing speeds, extended turning time, and reduced cadence compared to controls. Our model, after an integrated analysis of gait parameters, accurately identified early-stage PD patients. Moreover, the model indicated that gait parameters could predict the MDS-UPDRS III score using a machine learning regression approach.Conclusion: The non-contact gait assessment system facilitates the objective and quantitative evaluation of gait disorder in PD patients, effectively distinguishing those in the early stage from healthy individuals. The system holds significant potential for the early detection of PD. It also harnesses gait parameters for a reasoned prediction of the MDS-UPDRS III score, thereby quantifying disease severity. Overall, gait assessment is a valuable method for the early identification and ongoing monitoring of PD.

13 May 2024 in Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies
Verified
Journal Article
Open access
KLKaiyan Ling
Kaiyan Ling
HZHang Zhao
Hang Zhao
XFXiangmin Fan
Xiangmin Fan
XNXiaohui Niu
Xiaohui Niu
Wenchao YinWenchao Yin
Wenchao Yin
XBXiaojun Bi
Xiaojun Bi
Touch pointing is one of the primary interaction actions on mobile devices. In this research, we aim to (1) model touch pointing for people with Parkinson's Disease (PD), and (2) detect PD via touch pointing. We created a mobile game called MoleBuster in which a user performs a sequence of pointing actions. Our study with 40 participants shows that PD participants exhibited distinct pointing behavior. PD participants were much slower and had greater variances in movement time (MT), while their error rate was slightly lower than age-matched non-PD participants, indicating PD participants traded speed for accuracy. The nominal width Finger-Fitts law showed greater fitness than Fitts' law, suggesting this model should be adopted in lieu of Fitts' law to guide mobile interface design for PD users. We also proposed a CNN-Transformer-based neural network model to detect PD. Taking touch pointing data and comfort rating of finger movement as input, this model achieved an AUC of 0.97 and sensitivity of 0.95 in leave-one-user-out cross-validation. Overall, our research contributes models that reveal the temporal and spatial characteristics of touch pointing for PD users, and provide a new method (CNN-Transformer model) and a mobile game (MoleBuster) for convenient PD detection.

20 August 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
WYWenchao Yin
Wenchao Yin
HGHong Gao
Hong Gao
BLBeichen Liang
Beichen Liang
RLRuichen Liu
Ruichen Liu
YLYue Liu
Yue Liu
CWCui Wang
Cui Wang
Background: Gait disorder is one of the clinical manifestations of Parkinson’s disease (PD). Investigating the characteristics of gait disorder in patients with PD and the changes in gait before and after taking levodopa is crucial for the recognition, diagnosis and treatment of gait disorders in PD patients.Methods: In this study, we measured the gait parameters of 20 patients with PD and 17 healthy controls and analyzed the changes of gait parameters of these patients before and after taking levodopa. We also used gait parameters as input features and MDS-UPDRS III score (which was further subdivided into tremor and non-tremor part score) as output labels to train machine learning regression models.Results: We found that except for cadence and stride time, most gait parameters of PD patients, including plantar dorsiflexion angle, plantar flexion angle, stride length, velocity were all smaller than those of the healthy controls. Moreover, the severity of gait disorders correlated with the severity of motor symptoms. After taking levodopa, the stride length, velocity and cadence were increased, but stride time was decreased. We also found that the trained machine learning model could explain and predict the MDS-UPDRS III score and non-tremor part score, and the non-tremor part score was better than the MDS-UPDRS III score.Conclusion: Our gait assessment work can help clinicians recognize gait disorder in PD patients and predict the severity of clinical symptoms.

6 October 2025 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Open access
PDF file
WZWenying Zhang
Wenying Zhang
MQMingwei Qu
Mingwei Qu
CWCui Wang
Cui Wang
DSDejing Shang
Dejing Shang
The formation of Parkinson’s disease is affected by various factors, among which neuroinflammation mediated by microglial activation plays a crucial role in the advancement of neurodegenerative diseases. Antimicrobial peptides temporin-1CEa and its analog LK2(6)A(L) exhibit excellent anti-inflammatory activity. To understand the anti-neuroinflammatory mechanisms of antimicrobial peptides in an immortalized mouse microglial cell line (BV2 cells), and assess neuroprotective effects in a PC12 cell line (rat adrenal pheochromocytoma cell) and Caenorhabditis elegans. Lipopolysaccharide (LPS, 500 ng/mL) was used to induce neuroinflammation in microglial BV2 cells. The effects of antimicrobial peptides on inflammatory cytokines and anti-inflammatory pathways activated by microglia were evaluated using cell counting kit-8 (CCK-8), enzyme-linked immunosorbent assay (ELISA), real-time quantitative PCR(RT-qPCR), and western blotting (WB). An apoptosis model was established by treating PC12 cells with the supernatant of LPS-stimulated BV2 cells, and the influence of antimicrobial peptides on apoptosis was analyzed via flow cytometry (FCM), Western blotting, and caspase-3 and caspase-9 activity assays. In the transgenic nematode BZ555, an LPS (200 μg/mL)-induced model of cephalic dopaminergic neurons (CEPs) injury was developed to explore the protective effects of antimicrobial peptides on dopaminergic neuron damage, food-sensing behavior, body bending, neurotoxicity, and lifespan. Furthermore, NL5901 was employed to evaluate the capacity of antimicrobial peptides to clear the accumulation of alpha-synuclein (α-synuclein) and their impact on body bending, neurotoxicity, and lifespan. Temporin-1CEa and LK2(6)A(L) inhibited the release of pro-inflammatory mediators by downregulating the nuclear factor kappa-B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. At 3.125 μM, both temporin-1CEa and LK2(6)A(L) inhibited the apoptosis of PC12 cells induced by activated BV2 cells. In vivo experiments in nematodes demonstrated that temporin-1CEa and LK2(6)A(L) alleviated the damage to dopaminergic neurons induced by LPS and mitigated the capability to mitigate the accumulation of α-synuclein. In this study, antimicrobial peptides were shown to control inflammatory factors by downregulating the NF-κB and MAPK signaling pathways, thereby providing valuable insights for the agents in the neuroinflammation model of Parkinson’s disease. Additionally, an unexpected finding revealed that these peptides could effectively reduce the accumulation of α-synuclein, which is a critical pathogenic factor, as its aggregated forms significantly contribute to Parkinson’s disease progression. Notably, temporin-1CEa and LK2(6)A(L) exerted neuroprotective effects on dopaminergic neurons by inhibiting neuroinflammation and clearing the accumulation of α-synuclein.

13 October 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
WYWenchao Yin
Wenchao Yin
Hong GaoHong Gao
Hong Gao
RLRuichen Liu
Ruichen Liu
CSChenxin Shen
Chenxin Shen
YLYue Liu
Yue Liu
CWCui Wang
Cui Wang
Background: In Parkinson’s disease (PD) patients, the severity of motor symptoms is closely related to the degree of gait disorder and cognitive impairment; notably, the latter also exhibits a significant correlation with gait disorder. Evidently, there exists a complex relationship between motor symptoms, cognitive function, and gait characteristics.Methods: This study aims to conduct an in-depth analysis of the relationships among MDS-UPDRS III score, MoCA score, and gait parameters by constructing a mediation model.Results: We found that a higher MDS-UPDRS III score was associated with a smaller plantar dorsiflexion angle, slower velocity, and worse swing phase symmetry, and these associations were not mediated by the MoCA score. Age was a confounder in the relationship between MDS-UPDRS III score, MoCA, and velocity. A higher MDS-UPDRS III score was associated with shorter stride length, and this association was partially mediated by the MoCA score.Conclusion: The results indicated that, when analyzing plantar dorsiflexion angle and swing phase symmetry in PD patients, the influence of motor symptoms was dominant; when analyzing stride length, motor symptoms and cognitive function need to be considered simultaneously; when analyzing velocity, the influence of motor symptoms and age should be focused on.

19 November 2024 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
YCYingfei Chen
Yingfei Chen
YGYanan Gu
Yanan Gu
CCCan Cao
Can Cao
QZQiuying Zheng
Qiuying Zheng
LSLili Sun
Lili Sun
WZWenli Zhang
Wenli Zhang